Skip to main content
. 2024 Feb 6;14:3022. doi: 10.1038/s41598-024-53596-x

Table 5.

Antibiotic resistance of E. coli and K. pneumoniae strains producing ESBLs or showing resistance to carbapenems.

Pathogen (n) Ampicillin Amoxicillin-clavulanate Piperacillin-tazobactam Cefotaxime Ceftazidime Ceftriaxone Cefepime Ertapenem Imipenem Meropenem Amikacin Gentamicin Ciprofloxacin Nitrofurantoin Fosfomycin Norfloxacin TMP/SMX
Resistant isolates (% of tested)
E. coli ESBL (118) 118 (100) 59 (50.4) 24 (20.3) 114 (96.6) 114 (96.6) 114 (96.6) 110 (93.2) 0 0 0 2 (1.7) 40 (54.2) 87 (74.4) 5 (8.1) 2 (4.3) 48 (77.4) 87 (75.7)
K. pneumoniae ESBL (35) 35 (100) 22 (64.7) 10 (28.6) 35 (100) 34 (97.1) 35 (100) 32 (91.4) 0 0 0 0 15 (42.9) 20 (57.1) 11 (100) 0 4 (36.4) 26 (74.3)
E. coli CR (21) 14 (100) 13 (92.9) 13 (92.9) 14 (100) 14 (100) 14 (100) 14 (100) 13 (92,9) 12 (85.7) 13 (92.9) 2 (14.3) 8 (57.1) 14 (100) 3 (50) 1 (20) 6 (100) 11 (78.6)
K. pneumoniae CR (14) 21 (100) 21 (100) 21 (100) 21 (100) 21 (100) 21 (100) 19 (90.5) 20 (95.2) 20 (95.2) 20 (95.2) 15 (71.4) 13 (61.9) 19 (90.5) 6 (85.7) 5 (62.5) 7 (87.5) 16 (76.2)